Michel MS, Gschwend JE, Wullich B, Krege S, Bolenz C, Merseburger AS, Krabbe LM, Schultz-Lampel D, König F, Haferkamp A, Hadaschik B (2024)
Publication Type: Journal article
Publication year: 2024
Book Volume: 63
Pages Range: 893-898
Journal Issue: 9
DOI: 10.1007/s00120-024-02437-w
BACKGROUND AND OBJECTIVE: Despite the proven effectiveness of organized PSA-based screening in reducing prostate cancer-related mortality, there is currently no program in Germany covered by statutory health insurance. In accordance with the EU Council Decision (2022/0290(NLE)), the German Society of Urology (DGU) has developed a concept for risk-adapted prostate cancer early detection. MATERIALS AND METHODS: Based on a literature review of current screening studies, an algorithm for PSA-based prostate cancer early detection was developed. RESULTS: Risk-adapted prostate cancer screening involves PSA testing in the age group of 45-70 years, followed by PSA-based individual risk stratification and stepwise expansion of diagnostics through magnetic resonance imaging (MRI) to biopsy. While initially up to 2.6 million men will undergo PSA testing, a reduction in these initial examinations to fewer than 200,000 men per year will occur from year four onwards. CONCLUSIONS: The presented algorithm provides clear recommendations for risk-adapted PSA-based early detection for prostate cancer for urologists and patients. The goal is to improve diagnosis of clinically significant prostate cancer, while reducing overdiagnosis and overtreatment.
APA:
Michel, M.S., Gschwend, J.E., Wullich, B., Krege, S., Bolenz, C., Merseburger, A.S.,... Hadaschik, B. (2024). [Risk-adapted early detection program for prostate cancer 2.0-position paper of the German Society of Urology 2024]. Die Urologie, 63(9), 893-898. https://doi.org/10.1007/s00120-024-02437-w
MLA:
Michel, Maurice Stephan, et al. "[Risk-adapted early detection program for prostate cancer 2.0-position paper of the German Society of Urology 2024]." Die Urologie 63.9 (2024): 893-898.
BibTeX: Download